|Adult ADHD Home||Succeed at Work||ADHD Self Test|
|Love & Friendships||Manage Time & Money||ADHD Adult Blogs|
|The Organized Life||Stress, Sleep, Health||Adult Support Groups|
|Apps & Gadgets||Inspirational Stories||Expert Answers|
|ADHD Parenting Home||Schedules & Time||Sample Routines|
|Discipline & Behavior||Teens & Young Adults||Parent Support Group|
|ADHD Parenting Skills||Nutrition & Diet||Parenting Blogs|
|Friendships & Social Skills||Sports & Hobbies||Summer & Camps|
|ADHD Treatment Home||ADHD Medications||Medication Reviews||Adderall|
|Treating Your Child||Nutrition & Diet||Fish Oil Printable||Daytrana|
|Expert Q&As||Non-Medical Treatment||Find Professionals||Strattera|
|Behavior Therapy||Brain Training||Quillivant XR||Vyvanse|
|ADHD/LD School Home||High School & College||Accommodations|
|IEPs & 504s||ADHD Study Skills||ADHD School Guide|
|Working with School||School Organization Help||College Survival Guide|
|Social Skills at School||For Teachers Only||Is it LD? A Self Test|
|ADHD Diagnosis Home||ADHD & Women||Is it ADHD? Self Tests|
|Getting a Diagnosis||Is it a Related Condition?||Medical Q&As|
|ADHD Symptoms||Post Diagnosis Next Steps||Myths & Realities|
|Is it Learning Disabilities?||ADHD Treatment||ADHD Support Groups|
|Tools and Checklists|
|ADHD Topics A-Z|
|Share Your Story|
|Give a Gift|
|Buy Back Issues|
AD/HD Drugs and Cancer
Researchers report that children taking methylphenidate showed an increase in chromosome abnormalities that are associated with cancer.
Wednesday June 1st - 3:00pm
Do stimulant medications raise children's risk for cancer? High doses of methylphenidate - a constituent of Ritalin, Concerta, Metadate, and other AD/HD drugs - have been linked to liver tumors in mice, but not in rats. Now, Texas researchers report that each of a dozen kids treated for three months for AD/HD showed increased levels of chromosome abnormalities that are associated with cancer.
"It was pretty surprising that all of the children taking methylphenidate showed an increase in chromosome abnormalities in a relatively short period of time," said study author Randa A. El-Zein, M.D., Ph.D., assistant professor of epidemiology at the University of Texas M.D. Anderson Cancer Center in Houston. El-Zein stressed, however, that larger studies are needed to confirm his findings.
Co-author Matthew J. Hay, M.D., assistant professor of pediatrics at the University of Texas at Galveston, advised parents to respond cautiously to the news. "Twelve kids with one physician in one county is too small a sample to base a decision on," he said. "If my child were on the medication and doing well, I wouldn't take him off."
The study will be published in the journal Cancer Letters.